Does CYTARABINE Cause Rhabdomyosarcoma recurrent? 7 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Rhabdomyosarcoma recurrent have been filed in association with CYTARABINE (cytarabine). This represents 0.0% of all adverse event reports for CYTARABINE.
7
Reports of Rhabdomyosarcoma recurrent with CYTARABINE
0.0%
of all CYTARABINE reports
0
Deaths
0
Hospitalizations
How Dangerous Is Rhabdomyosarcoma recurrent From CYTARABINE?
Of the 7 reports.
Is Rhabdomyosarcoma recurrent Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CYTARABINE. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does CYTARABINE Cause?
Febrile neutropenia (6,142)
Off label use (4,183)
Pyrexia (2,992)
Neutropenia (2,558)
Disease progression (2,352)
Drug ineffective (2,281)
Thrombocytopenia (2,148)
Sepsis (2,013)
Myelosuppression (1,869)
Product use in unapproved indication (1,619)
What Other Drugs Cause Rhabdomyosarcoma recurrent?
CYCLOPHOSPHAMIDE (19)
IFOSFAMIDE (19)
VINCRISTINE (18)
ETOPOSIDE (17)
DOXORUBICIN (14)
CARBOPLATIN (12)
DACTINOMYCIN (12)
IRINOTECAN (12)
TOPOTECAN (10)
IDARUBICIN (9)
Which CYTARABINE Alternatives Have Lower Rhabdomyosarcoma recurrent Risk?
CYTARABINE vs CYTARABINE\DAUNORUBICIN
CYTARABINE vs DABIGATRAN
CYTARABINE vs DABIGATRAN ETEXILATE
CYTARABINE vs DABRAFENIB
CYTARABINE vs DABRAFENIB\TRAMETINIB